Key facts
- Artisight’s last known valuation is $163.5M (Oct 2024).
- It has raised $51.3M; the latest was Later Stage VC in Dec 2025.
- Notable investors include Microsoft for Startups, Nvidia, Labcorp Venture Fund, Epsilon Health, Epsilon Health. — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Artisight
- ·The full record, as it builds
Funding rounds
No funding rounds for Artisight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Artisight
Developer of an IoT sensor network designed to improve organizational operations and financial performance for healthcare. The company's platform uses artificial intelligence technology to analyze data and generate new and previously inaccessible data sets, enabling healthcare organizations to maximize profitability while reducing the need to interact with healthcare information systems.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2015
- Employees
- 125
- Website
- artisight.com/
- Ownership
- Privately Held (backing)
Artisight doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Artisight shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Artisight in its N-PORT filings yet. We sweep new filings monthly.